Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1996;93:704-711

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Torre-Amione, G.
Right arrow Articles by Mann, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Torre-Amione, G.
Right arrow Articles by Mann, D. L.

(Circulation. 1996;93:704-711.)
© 1996 American Heart Association, Inc.


Articles

Tumor Necrosis Factor-{alpha} and Tumor Necrosis Factor Receptors in the Failing Human Heart

Guillermo Torre-Amione, MD, PhD; Samir Kapadia, MD; Joseph Lee, MD; Jean-Bernard Durand, MD; Roger D. Bies, MD; James B. Young, MD; Douglas L. Mann, MD

From the Cardiology Section of the Department of Medicine, Veterans Administration Medical Center, and Baylor College of Medicine, Houston, Tex; and the Cardiology Section of the Department of Medicine, University of Colorado, Denver (R.D.B.).

Background Tumor necrosis factor-{alpha} (TNF-{alpha}) is a proinflammatory cytokine that produces negative inotropic effects in the heart. Recently, elevated levels of TNF-{alpha} have been reported in patients with advanced congestive heart failure. Although TNF-{alpha} is thought to exert its deleterious effects by binding to two cell surface receptors, TNFR1 and TNFR2, the level of expression and regulation of TNF receptors in the heart in cardiac disease states is not known.

Methods and Results We examined mRNA and protein levels for TNFR1, TNFR2, and TNF-{alpha} in explanted hearts from organ donors as well as in patients with end-stage dilated cardiomyopathy (DCM) and ischemic heart disease (IHD). Northern blot analysis revealed that mRNA for TNFR1 and TNFR2 was present in nonfailing, DCM, and IHD hearts. TNFR1 and TNFR2 receptor protein levels, as measured by ELISA, were decreased 60% in DCM and IHD patients compared with nonfailing hearts (P<.005). To determine a potential mechanism for the decrease in TNF receptor expression, we measured levels of circulating soluble TNF receptors (sTNFRs) in DCM and IHD patients. This analysis showed that there was a significant one-and-a-half to threefold increase in sTNFRs in DCM (P<.03) and IHD patients (P<.001). Another important finding was that TNF-{alpha} mRNA and TNF-{alpha} protein were present in the explanted hearts from DCM and IHD patients but not in nonfailing hearts.

Conclusions In summary, the results of this study constitute the initial demonstration that TNF receptor proteins are dynamically regulated in patients with advanced congestive heart failure. Moreover, the observation that failing hearts express elevated levels of TNF-{alpha} suggests that overexpression of this cytokine may be one of several different maladaptive mechanisms responsible for the progressive cardiac decompensation that occurs in advanced heart failure.


Key Words: cells, tumor necrosis factor-{alpha} • receptors • heart failure




This article has been cited by other articles:


Home page
J. Cell Biol.Home page
P. Panagopoulou, C. H. Davos, D. J. Milner, E. Varela, J. Cameron, D. L. Mann, and Y. Capetanaki
Desmin mediates TNF-{alpha}-induced aggregate formation and intercalated disk reorganization in heart failure
J. Cell Biol., May 28, 2008; 181(5): 761 - 775.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
G. Mercuro, C. Cadeddu, A. Piras, M. Dessi, C. Madeddu, M. Deidda, R. Serpe, E. Massa, and G. Mantovani
Early Epirubicin-Induced Myocardial Dysfunction Revealed by Serial Tissue Doppler Echocardiography: Correlation with Inflammatory and Oxidative Stress Markers
Oncologist, September 1, 2007; 12(9): 1124 - 1133.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. L. Goodwin, L. C. Pendleton, M. M. Levy, L. P. Solomonson, and D. C. Eichler
Tumor necrosis factor-{alpha} reduces argininosuccinate synthase expression and nitric oxide production in aortic endothelial cells
Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1115 - H1121.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Monden, T. Kubota, T. Inoue, T. Tsutsumi, S. Kawano, T. Ide, H. Tsutsui, and K. Sunagawa
Tumor necrosis factor-{alpha} is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H743 - H753.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Guggilam, M. Haque, E. K. Kerut, E. McIlwain, P. Lucchesi, I. Seghal, and J. Francis
TNF-{alpha} blockade decreases oxidative stress in the paraventricular nucleus and attenuates sympathoexcitation in heart failure rats
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H599 - H609.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. D. DeBoer, X. X. Zhu, P. Levasseur, M. M. Meguid, S. Suzuki, A. Inui, J. E. Taylor, H. A. Halem, J. Z. Dong, R. Datta, et al.
Ghrelin Treatment Causes Increased Food Intake and Retention of Lean Body Mass in a Rat Model of Cancer Cachexia
Endocrinology, June 1, 2007; 148(6): 3004 - 3012.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Shiroshita-Takeshita, B. J.J.M. Brundel, B. Burstein, T.-K. Leung, H. Mitamura, S. Ogawa, and S. Nattel
Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure
Cardiovasc Res, April 1, 2007; 74(1): 75 - 84.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Monden, T. Kubota, T. Tsutsumi, T. Inoue, S. Kawano, N. Kawamura, T. Ide, K. Egashira, H. Tsutsui, and K. Sunagawa
Soluble TNF receptors prevent apoptosis in infiltrating cells and promote ventricular rupture and remodeling after myocardial infarction
Cardiovasc Res, March 1, 2007; 73(4): 794 - 805.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Wohlschlaeger, K. J. Schmitz, J. Palatty, A. Takeda, N. Takeda, C. Vahlhaus, B. Levkau, J. Stypmann, C. Schmid, K. W. Schmid, et al.
Roles of cyclooxygenase-2 and phosphorylated Akt ( T hr308) in cardiac hypertrophy regression mediated by left-ventricular unloading
J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 37 - 43.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
V. Adams, A. Linke, U. Wisloff, C. Doring, S. Erbs, N. Krankel, C. C. Witt, S. Labeit, U. Muller-Werdan, G. Schuler, et al.
Myocardial expression of Murf-1 and MAFbx after induction of chronic heart failure: Effect on myocardial contractility
Cardiovasc Res, January 1, 2007; 73(1): 120 - 129.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. N. Mazzadi, X. Andre-Fouet, N. Costes, P. Croisille, D. Revel, and M. F. Janier
Mechanisms leading to reversible mechanical dysfunction in severe CAD: alternatives to myocardial stunning
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2570 - H2582.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. S. Hoare, E. J. Birks, C. Bowles, N. Marczin, and M. H. Yacoub
In vitro endothelial cell activation and inflammatory responses in end-stage heart failure
J Appl Physiol, November 1, 2006; 101(5): 1466 - 1473.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. R. van Kimmenade, J. L. Januzzi Jr, P. T. Ellinor, U. C. Sharma, J. A. Bakker, A. F. Low, A. Martinez, H. J. Crijns, C. A. MacRae, P. P. Menheere, et al.
Utility of Amino-Terminal Pro-Brain Natriuretic Peptide, Galectin-3, and Apelin for the Evaluation of Patients With Acute Heart Failure
J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1217 - 1224.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Kawano, T. Kubota, Y. Monden, T. Tsutsumi, T. Inoue, N. Kawamura, H. Tsutsui, and K. Sunagawa
Blockade of NF-{kappa}B improves cardiac function and survival after myocardial infarction
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1337 - H1344.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. A. Jankowska, P. Ponikowski, M. F. Piepoli, W. Banasiak, S. D. Anker, and P. A. Poole-Wilson
Autonomic imbalance and immune activation in chronic heart failure - Pathophysiological links
Cardiovasc Res, June 1, 2006; 70(3): 434 - 445.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. S. Petkova-Kirova, E. Gursoy, H. Mehdi, C. F. McTiernan, B. London, and G. Salama
Electrical remodeling of cardiac myocytes from mice with heart failure due to the overexpression of tumor necrosis factor-{alpha}
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2098 - H2107.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. S Schleithoff, A. Zittermann, G. Tenderich, H. K Berthold, P. Stehle, and R. Koerfer
Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial.
Am. J. Clinical Nutrition, April 1, 2006; 83(4): 754 - 759.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Rutschow, J. Li, H.-P. Schultheiss, and M. Pauschinger
Myocardial proteases and matrix remodeling in inflammatory heart disease
Cardiovasc Res, February 15, 2006; 69(3): 646 - 656.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. M. Deschamps and F. G. Spinale
Pathways of matrix metalloproteinase induction in heart failure: Bioactive molecules and transcriptional regulation
Cardiovasc Res, February 15, 2006; 69(3): 666 - 676.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Chao, Y. Shen, L. Li, H. Zhao, S. E. Meiler, S. A. Cook, and A. Rosenzweig
Fas-associated death-domain protein inhibits TNF-{alpha} mediated NF-{kappa}B activation in cardiomyocytes
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2073 - H2080.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Hall, I. S. Singh, L. Hester, J. D. Hasday, and T. B. Rogers
Inhibitor-{kappa}B kinase-{beta} regulates LPS-induced TNF-{alpha} production in cardiac myocytes through modulation of NF-{kappa}B p65 subunit phosphorylation
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2103 - H2111.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Levrand, B. Pesse, F. Feihl, B. Waeber, P. Pacher, J. Rolli, M.-D. Schaller, and L. Liaudet
Peroxynitrite Is a Potent Inhibitor of NF-{kappa}B Activation Triggered by Inflammatory Stimuli in Cardiac and Endothelial Cell Lines
J. Biol. Chem., October 14, 2005; 280(41): 34878 - 34887.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Z. Kassiri, G. Y. Oudit, O. Sanchez, F. Dawood, F. F. Mohammed, R. K. Nuttall, D. R. Edwards, P. P. Liu, P. H. Backx, and R. Khokha
Combination of Tumor Necrosis Factor-{alpha} Ablation and Matrix Metalloproteinase Inhibition Prevents Heart Failure After Pressure Overload in Tissue Inhibitor of Metalloproteinase-3 Knock-Out Mice
Circ. Res., August 19, 2005; 97(4): 380 - 390.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. M. Schiotz Thorud, A. Stranda, J.-A. Birkeland, P. K. Lunde, I. Sjaastad, S. O. Kolset, O. M. Sejersted, and P. O. Iversen
Enhanced matrix metalloproteinase activity in skeletal muscles of rats with congestive heart failure
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R389 - R394.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M Vanderheyden, W J Paulus, M Voss, P Knuefermann, N Sivasubramanian, D Mann, and G Baumgarten
Myocardial cytokine gene expression is higher in aortic stenosis than in idiopathic dilated cardiomyopathy
Heart, July 1, 2005; 91(7): 926 - 931.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
J. M. Seddon, S. George, B. Rosner, and N. Rifai
Progression of Age-Related Macular Degeneration: Prospective Assessment of C-Reactive Protein, Interleukin 6, and Other Cardiovascular Biomarkers
Arch Ophthalmol, June 1, 2005; 123(6): 774 - 782.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Kawamura, T. Kubota, S. Kawano, Y. Monden, A. M. Feldman, H. Tsutsui, A. Takeshita, and K. Sunagawa
Blockade of NF-{kappa}B improves cardiac function and survival without affecting inflammation in TNF-{alpha}-induced cardiomyopathy
Cardiovasc Res, June 1, 2005; 66(3): 520 - 529.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Li, D. Georgakopoulos, G. Lu, L. Hester, D. A. Kass, J. Hasday, and Y. Wang
p38 MAP Kinase Mediates Inflammatory Cytokine Induction in Cardiomyocytes and Extracellular Matrix Remodeling in Heart
Circulation, May 17, 2005; 111(19): 2494 - 2502.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. J. Toth, D. E. Matthews, P. A. Ades, M. D. Tischler, P. Van Buren, M. Previs, and M. M. LeWinter
Skeletal muscle myofibrillar protein metabolism in heart failure: relationship to immune activation and functional capacity
Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E685 - E692.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. P. Curtis, J. G. Selter, Y. Wang, S. S. Rathore, I. S. Jovin, F. Jadbabaie, M. Kosiborod, E. L. Portnay, S. I. Sokol, F. Bader, et al.
The Obesity Paradox: Body Mass Index and Outcomes in Patients With Heart Failure
Arch Intern Med, January 10, 2005; 165(1): 55 - 61.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
K L Hyrich, A J Silman, K D Watson, and D P M Symmons
Anti-tumour necrosis factor {alpha} therapy in rheumatoid arthritis: an update on safety
Ann Rheum Dis, December 1, 2004; 63(12): 1538 - 1543.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
F. Langer, R. Schramm, M. Bauer, D. Tscholl, T. Kunihara, and H.-J. Schafers
Cytokine Response to Pulmonary Thromboendarterectomy
Chest, July 1, 2004; 126(1): 135 - 141.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
R. de Vroege, W. van Oeveren, J. van Klarenbosch, W. Stooker, M. A. J. M. Huybregts, C. E. Hack, L. van Barneveld, L. Eijsman, and C. R. H. Wildevuur
The Impact of Heparin-Coated Cardiopulmonary Bypass Circuits on Pulmonary Function and the Release of Inflammatory Mediators
Anesth. Analg., June 1, 2004; 98(6): 1586 - 1594.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y.-C. Fu, C.-S. Chi, S.-C. Yin, B. Hwang, Y.-T. Chiu, and S.-L. Hsu
Norepinephrine induces apoptosis in neonatal rat cardiomyocytes through a reactive oxygen species-TNF{alpha}-caspase signaling pathway
Cardiovasc Res, June 1, 2004; 62(3): 558 - 567.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Sasaki, T. Osanai, H. Tomita, T. Matsunaga, K. Magota, and K. Okumura
Tumor necrosis factor {alpha} as an endogenous stimulator for circulating coupling factor 6
Cardiovasc Res, June 1, 2004; 62(3): 578 - 586.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Higuchi, C. F. McTiernan, C. B. Frye, B. S. McGowan, T. O. Chan, and A. M. Feldman
Tumor Necrosis Factor Receptors 1 and 2 Differentially Regulate Survival, Cardiac Dysfunction, and Remodeling in Transgenic Mice With Tumor Necrosis Factor-{alpha}-Induced Cardiomyopathy
Circulation, April 20, 2004; 109(15): 1892 - 1897.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. M. Delgado III, M. A. Nawar, A. M. Zewail, B. Kar, W. K. Vaughn, K. K. Wu, N. Aleksic, N. Sivasubramanian, K. McKay, D. L. Mann, et al.
Cyclooxygenase-2 Inhibitor Treatment Improves Left Ventricular Function and Mortality in a Murine Model of Doxorubicin-Induced Heart Failure
Circulation, March 23, 2004; 109(11): 1428 - 1433.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Sliwa, A. Woodiwiss, V. N. Kone, G. Candy, D. Badenhorst, G. Norton, C. Zambakides, F. Peters, and R. Essop
Therapy of Ischemic Cardiomyopathy With the Immunomodulating Agent Pentoxifylline: Results of a Randomized Study
Circulation, February 17, 2004; 109(6): 750 - 755.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. M. Feldman
The emerging role of pharmacogenomics in the treatment of patients with heart failure
Ann. Thorac. Surg., December 1, 2003; 76(6): S2246 - 2253.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
H. Tomasdottir, H. Hjartarson, A. Ricksten, C. Wasslavik, A. Bengtsson, and S.-E. Ricksten
Tumor Necrosis Factor Gene Polymorphism Is Associated with Enhanced Systemic Inflammatory Response and Increased Cardiopulmonary Morbidity After Cardiac Surgery
Anesth. Analg., October 1, 2003; 97(4): 944 - 949.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Gattenlohner, C. Waller, G. Ertl, B.-D. Bultmann, H.-K. Muller-Hermelink, and A. Marx
NCAM(CD56) and RUNX1(AML1) Are Up-Regulated in Human Ischemic Cardiomyopathy and a Rat Model of Chronic Cardiac Ischemia
Am. J. Pathol., September 1, 2003; 163(3): 1081 - 1090.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Z. I. Dibbs, A. Diwan, S. Nemoto, G. DeFreitas, M. Abdellatif, B. A. Carabello, F. G. Spinale, G. Feuerstein, N. Sivasubramanian, and D. L. Mann
Targeted Overexpression of Transmembrane Tumor Necrosis Factor Provokes a Concentric Cardiac Hypertrophic Phenotype
Circulation, August 26, 2003; 108(8): 1002 - 1008.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Aker, S. Belosjorow, I. Konietzka, A. Duschin, C. Martin, G. Heusch, and R. Schulz
Serum but not myocardial TNF-{alpha} concentration is increased in pacing-induced heart failure in rabbits
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R463 - R469.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. R. Murray and G. L. Freeman
Proinflammatory Cytokines: Predictors of a Failing Heart?
Circulation, March 25, 2003; 107(11): 1460 - 1462.
[Full Text] [PDF]


Home page
CirculationHome page
H. Oral, N. Sivasubramanian, D. B. Dyke, R. H. Mehta, P. M. Grossman, K. Briesmiester, W. P. Fay, F. D. Pagani, S. F. Bolling, D. L. Mann, et al.
Myocardial Proinflammatory Cytokine Expression and Left Ventricular Remodeling in Patients With Chronic Mitral Regurgitation
Circulation, February 18, 2003; 107(6): 831 - 837.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. London, L. C. Baker, J. S. Lee, V. Shusterman, B.-R. Choi, T. Kubota, C. F. McTiernan, A. M. Feldman, and G. Salama
Calcium-dependent arrhythmias in transgenic mice with heart failure
Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H431 - H441.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Machida, T. Kubota, N. Kawamura, H. Funakoshi, T. Ide, H. Utsumi, Y. Y. Li, A. M. Feldman, H. Tsutsui, H. Shimokawa, et al.
Overexpression of tumor necrosis factor-alpha increases production of hydroxyl radical in murine myocardium
Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H449 - H455.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. L. Brutsaert
Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity
Physiol Rev, January 1, 2003; 83(1): 59 - 115.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Steenbergen, C. A. Afshari, J. G. Petranka, J. Collins, K. Martin, L. Bennett, A. Haugen, P. Bushel, and E. Murphy
Alterations in apoptotic signaling in human idiopathic cardiomyopathic hearts in failure
Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H268 - H276.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Scheubel, M. Tostlebe, A. Simm, S. Rohrbach, R. Prondzinsky, F. N. Gellerich, R.-E. Silber, and J. Holtz
Dysfunction of mitochondrial respiratory chain complex I in human failing myocardium is not due to disturbed mitochondrial gene expression
J. Am. Coll. Cardiol., December 18, 2002; 40(12): 2174 - 2181.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
V.M. Conraads, P. Beckers, J. Bosmans, L.S. De Clerck, W.J. Stevens, C.J. Vrints, and D.L. Brutsaert
Combined endurance/resistance training reduces plasma TNF-{alpha} receptor levels in patients with chronic heart failure and coronary artery disease
Eur. Heart J., December 1, 2002; 23(23): 1854 - 1860.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
S.B. Felix, A. Staudt, and G. Baumann
Immunoadsorption as a new therapeutic principle for treatment of dilated cardiomyopathy
Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I63 - I68.
[Abstract] [PDF]


Home page
Circ. Res.Home page
D. L. Mann
Inflammatory Mediators and the Failing Heart: Past, Present, and the Foreseeable Future
Circ. Res., November 29, 2002; 91(11): 988 - 998.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. R. R. Heyen, E. R. Blasi, K. Nikula, R. Rocha, H. A. Daust, G. Frierdich, J. F. Van Vleet, P. De Ciechi, E. G. McMahon, and A. E. Rudolph
Structural, functional, and molecular characterization of the SHHF model of heart failure
Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1775 - H1784.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
Y. Fromes, D. Gaillard, O. Ponzio, M. Chauffert, M.-F. Gerhardt, P. Deleuze, and O. M. Bical
Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation
Eur. J. Cardiothorac. Surg., October 1, 2002; 22(4): 527 - 533.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Chen, J. H. Traverse, R. Du, M. Hou, an